Pediatric Nephrology

IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth

Burkhard Tönshoff, Franz Schaefer, Frederick J. Kaskel

The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting

Shoshana Yakar, Hyunsook Kim, Hong Zhao, Yuka Toyoshima, Patricia Pennisi, Oksana Gavrilova, Derek LeRoith

Allelic differences in a quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition

Clifford J. Rosen, Cheryl Ackert-Bicknell, Wesley G. Beamer, Tracy Nelson, Martin Adamo, Pinchas Cohen, Mary L. Bouxsein, Mark C. Horowitz

The multi-functional role of insulin-like growth factor binding proteins in bone

Kristen E. Govoni, David J. Baylink, Subburaman Mohan

Functional consequences of IGFBP excess—lessons from transgenic mice

Eckhard Wolf, Marlon R. Schneider, Rui Zhou, Thomas M. Fisch, Nadja Herbach, Maik Dahlhoff, Rüdiger Wanke, Andreas Hoeflich

Growth hormone/insulin-like growth factor system in children with chronic renal failure

Burkhard Tönshoff, Daniela Kiepe, Sonia Ciarmatori

Recombinant insulin-like growth factor-1 as a therapy for IGF-1 deficiency in renal failure

Ross G. Clark

Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system

Joachim Woelfle, Dennis J. Chia, Mylynda B. Massart-Schlesinger, Paula Moyano, Peter Rotwein

Identification of the first patient with a confirmed mutation of the JAK-STAT system

Ron G. Rosenfeld, Eric Kofoed, Caroline Buckway, Brian Little, Katie A. Woods, Junko Tsubaki, Katherine A. Pratt, Liliana Bezrodnik, Hector Jasper, Alejandro Tepper, Juan J. Heinrich, Vivian Hwa

Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance

Charles H. Lang, Ly Hong-Brown, Robert A. Frost

Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling

Ralph Rabkin, Di Fei Sun, Yu Chen, Jane Tan, Franz Schaefer

Impact of growth plate senescence on catch-up growth and epiphyseal fusion

Ola Nilsson, Jeffrey Baron

Genomic and non-genomic actions of sex steroids in the growth plate

Marcel Karperien, Bram C. J. van der Eerden, Jan Maarten Wit

Alterations of the growth plate in chronic renal failure

Fernando Santos, Eduardo Carbajo-Pérez, Julián Rodríguez, Marta Fernández-Fuente, Inés Molinos, Benito Amil, Enrique García

Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation

Sylvia C. van Buul-Offers, Jeske J. Smink, Ria Gresnigt, Nicole Hamers, Joost Koedam, Marcel Karperien

Pathogenesis of parathyroid dysfunction in end-stage kidney disease

Ronen Levi, Justin Silver

Structural organization and biological relevance of oscillatory parathyroid hormone secretion

C. P. Schmitt, M. Hömme, F. Schaefer

Genetic regulation of bone mass: from bone density to bone strength

Craig B. Langman

The “functional muscle-bone unit”: a two-step diagnostic algorithm in pediatric bone disease

Eckhard Schoenau

Assessment of bone mass following renal transplantation in children

Mary B. Leonard

Pamidronate treatment of pediatric fracture patients on chronic steroid therapy

Philip D. Acott, Jaime A. Wong, Bianca A. Lang, John F. S. Crocker

Cardiovascular disease as a late complication of end-stage renal disease in children

Jaap W. Groothoff, Marc R. Lilien, Nicole C. A. J. van de Kar, Eric D. Wolff, Jean Claude Davin

Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease

Z. A. Massy, C. Mazière, S. Kamel, M. Brazier, G. Choukroun, C. Tribouilloy, M. Slama, M. Andrejak, J. C. Mazière

“Missing” inhibitors of calcification: general aspects and implications in renal failure

Markus Ketteler, Ralf Westenfeld, Georg Schlieper, Vincent Brandenburg, Jürgen Floege

The therapeutic potential of novel phosphate binders

Uwe Querfeld

Are new vitamin D analogues in renal bone disease superior to calcitriol?

Isidro B. Salusky

Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means

Tilman B. Drüeke

Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry

Richard N. Fine, Donald Stablein

Steroid withdrawal in pediatric and adult renal transplant recipients

Burkhard Tönshoff, Britta Höcker, Lutz T. Weber

Corticosteroid avoidance in pediatric renal transplantation

Jayakumar R. Vidhun, Minnie M. Sarwal

Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease

Robert H. Mak, Wai Cheung, Roger D. Cone, Daniel L. Marks

Rapid development of glomerular injury and renal failure in mice lacking p53R2

David R. Powell, Urvi Desai, Mary Jean Sparks, Gwenn Hansen, Jason Gay, Jeff Schrick, Zheng-Zheng Shi, John Hicks, Peter Vogel

IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth, 1 - 3 April 2004, Heidelberg, Germany